The Effect of Sales Growth and Operating Expenses on Net Profit at PT. Indofarma Tbk for the 2015-2024 Period

Ghevira Reviani; Hendri Prasetyo

doi:10.61536/escalate.v4i4.784

Authors

Ghevira Reviani Program Studi Manajemen Fakultas Ekonomi Dan Bisnis Universitas Pamulang Tangerang Selatan
Hendri Prasetyo Program Studi Manajemen Fakultas Ekonomi Dan Bisnis Universitas Pamulang Tangerang Selatan

DOI:

https://doi.org/10.61536/escalate.v4i4.784

Keywords:

Operating Expenses, Pharmaceutical Industry, Financial Performance, Net Profit, Sales Growth

Abstract

This study examines the relationship between sales growth, operating expenses, and net profit at PT Indofarma Tbk during 2015–2024. Using a quantitative approach, the study analyzes secondary data from 10 annual financial statements. Data were analyzed using descriptive statistics, classical assumption tests, multiple linear regression, and t-tests and F-tests with SPSS version 26. The results indicate that sales growth has a positive and statistically significant relationship with net profit ((t = 2.954); (p = 0.021)). Operating expenses also show a positive and statistically significant relationship with net profit ((t = 8.329); (p < 0.001)). Jointly, both variables are statistically significant in the model ((F = 38.182); (p < 0.001)). The (R^2) value of 0.916 indicates that the model accounts for 91.6% of the variation in net profit within the observed sample. The positive operating expense coefficient should be interpreted in the context of the study’s measurement and the company’s financial data, rather than as evidence that higher expenses necessarily improve performance.

Downloads

Download data is not yet available.

References

Algifari. (2017). Analisis regresi untuk bisnis dan ekonomi. BPFE.

Fitrianingsih, D. (2025). Sales growth, account receivable turn over dan inventory turn over mempengaruhi laba bersih pada perusahaan farmasi yang terdaftar di BEI. Jurnal Ilmiah Manajemen, 4(2), 78–85.

Handayani, T. (2023). Pengaruh biaya operasional dan pertumbuhan penjualan terhadap profitabilitas pada perusahaan manufaktur sub sektor farmasi periode 2017–2021. Jurnal Administrasi Bisnis FISIPOL UNMUL, 11(3), 205–218.

Kasmir. (2019). Analisis laporan keuangan (Edisi revisi). PT RajaGrafindo Persada.

Kasmir. (2023). Analisis laporan keuangan. Rajawali Pers.

Lestari, A. P., Yudi, Y., & Yuliusman, Y. (2025). Pengaruh biaya produksi, biaya operasional dan penjualan terhadap laba bersih pada perusahaan sektor industri dasar dan kimia di Bursa Efek Indonesia tahun 2020–2024. Jambi Accounting Review, 6(2), 56–81. https://online-journal.unja.ac.id/JAR/article/view/51924

Putri, L. A. (2021). Pengaruh biaya operasional, biaya produksi, dan volume penjualan terhadap laba bersih (Studi pada perusahaan manufaktur sub sektor farmasi yang terdaftar di Bursa Efek Indonesia periode 2015–2019). Telkom University. https://openlibrarypublications.telkomuniversity.ac.id/index.php/management/article/view/16738

Rachmad, Y. E., Rahman, A., Judijanto, L., Pudjiarti, E. S., Runtunuwu, P. C. H., Lestari, N. E., Wulandari, D., Suhirman, L., Rahmawati, F. A., Mukhlis, I. R., Fatmah, Saktisyahputra, Purba, A. E., Nopiah, R., Winarni, A. T., Fanani, A. F., & Mintarsih. (2024). Integrasi metode kuantitatif dan kualitatif: Panduan praktis penelitian campuran. PT Green Pustaka Indonesia.

Supriadi, I. (2020). Metode riset akuntansi. Deepublish.

Suryani, A. I., & Orinaldi, M. (2024). Pengaruh modal kerja, biaya produksi dan penjualan terhadap laba bersih pada perusahaan sub sektor farmasi yang terdaftar di Indeks Saham Syariah Indonesia tahun 2019–2023. Jurnal Penelitian Ilmiah Multidisiplin, 8(12).

Wahyuni, L., Defitri, S. Y., Ramadani, F. P., Fitri, N. A., & Salman, A. (2026). Pengaruh pendapatan usaha dan beban operasional terhadap laba bersih pada perusahaan sub sektor farmasi yang terdaftar di BEI pada tahun 2021–2024. Jurnal Transformasi Ekonomi dan Inovasi Keuangan, 10(1).